ALLMedicine™ Ankylosing Spondylitis Center
Research & Reviews 7,803 results
https://doi.org/10.3928/23258160-20210201-07
Ophthalmic Surgery, Lasers & Imaging Retina; Plemel DJA, Seamone ME et. al.
Feb 24th, 2021 - The authors describe the case of a 25-year-old male who presented with a cilioretinal artery occlusion secondary to posterior scleritis. The patient had a history of juvenile spondyloarthritis that evolved into ankylosing spondylitis. Cilioretinal...
https://doi.org/10.1097/BRS.0000000000003800
Spine Huang JC, Qian BP et. al.
Feb 23rd, 2021 - A retrospective study. The aim of this study was to make a thorough comparison of clinical and radiographic outcomes between ankylosing spondylitis (AS) patients with severe kyphosis who underwent one- or two-level pedicle subtraction osteotomy (P...
https://doi.org/10.1007/s10067-021-05642-6 10.1016/S0140-6736(16)31591-4 10.1002/acr.21621 10.1002/art.1780270401 10.1136/ard.2009.108233 10.1002/art.24483 10.1136/annrheumdis-2015-208852 10.1002/art.37803 10.1002/art.39666 10.1136/ard.2010.145995 10.1002/art.39542 10.1002/acr.21688 10.3899/jrheum.130588 10.1136/ard.2009.108217 10.1111/1756-185X.12579 10.1136/annrheumdis-2012-202389 10.1185/03007990802457040 10.1136/ard.2008.097774 10.1136/annrheumdis-2013-203967 10.1093/rheumatology/ker377 10.1007/1-4020-5511-0 10.1093/rheumatology/kep457 10.1002/art.38140 10.1002/acr.23534 10.1186/s13075-018-1724-7 10.1136/ard.2009.124206 10.1097/BOR.0000000000000071 10.1002/art.38973 10.1136/annrheumdis-2013-204231
Clinical Rheumatology; Hunter T, Sandoval D et. al.
Feb 21st, 2021 - The aim of this study was to compare the symptoms, treatment patterns, and quality of life (QoL) of ankylosing spondylitis (AS) patients to non-radiographic axial spondyloarthritis (nr-axSpA) patients in the USA. A cross-sectional survey was condu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896408
Arthritis Research & Therapy; Liu M, Xie Z et. al.
Feb 21st, 2021 - Osteoarthritis (OA) is the most prevalent form of arthritis and the major cause of disability and overall diminution of quality of life in the elderly population. Currently there is no cure for OA, partly due to the large gaps in our understanding...
https://doi.org/10.1111/1756-185X.14080
International Journal of Rheumatic Diseases; Yang H, Chen Y et. al.
Feb 20th, 2021 - Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease which mainly affects the spine, sacroiliac joint and peripheral joints. To date, the exact causes and pathogenesis of AS still remain unknown. It is considered that the patho...
Guidelines 37 results
https://www.rheumatology.org/Portals/0/Files/AxialSpA-Guideline-2019.pdf
Ward MM,et al
Sep 30th, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). ankylosing spondylitis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.
Aug 22nd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...
https://www.businesswire.com/news/home/20190723006033/en/FDA-Approves-Samsung-Bioepis-HADLIMA%E2%84%A2-adalimumab-bwwd
Jul 23rd, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® i (adalimumab), for the treatment of rheumatoid arthritis, juvenile idiopathic arthr...
http://www.samsungbioepis.com/en/newsroom/detail/FDA-Approves-ETICOVO-Samsung-Bioepis-Second-Anti-TNF-Medicine.html
Apr 28th, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL® (etanercept), across all eligible indications for the treatment of rheumatoid arthri...
https://www.rheumatology.org/Portals/0/Files/ACR-AAHKS-Perioperative-Management-Guideline.pdf
Goodman, S.,et al
Jul 31st, 2017 - This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid a.
Drugs 1,113 results see all →
Clinicaltrials.gov 9,411 results
https://doi.org/10.3928/23258160-20210201-07
Ophthalmic Surgery, Lasers & Imaging Retina; Plemel DJA, Seamone ME et. al.
Feb 24th, 2021 - The authors describe the case of a 25-year-old male who presented with a cilioretinal artery occlusion secondary to posterior scleritis. The patient had a history of juvenile spondyloarthritis that evolved into ankylosing spondylitis. Cilioretinal...
https://doi.org/10.1097/BRS.0000000000003800
Spine Huang JC, Qian BP et. al.
Feb 23rd, 2021 - A retrospective study. The aim of this study was to make a thorough comparison of clinical and radiographic outcomes between ankylosing spondylitis (AS) patients with severe kyphosis who underwent one- or two-level pedicle subtraction osteotomy (P...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b4c1a15-ed93-7192-e053-2991aa0a8360
Feb 22nd, 2021 - Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. Use the lowest effective dose for the shortest duration consistent with individual pati...
https://doi.org/10.1007/s10067-021-05642-6 10.1016/S0140-6736(16)31591-4 10.1002/acr.21621 10.1002/art.1780270401 10.1136/ard.2009.108233 10.1002/art.24483 10.1136/annrheumdis-2015-208852 10.1002/art.37803 10.1002/art.39666 10.1136/ard.2010.145995 10.1002/art.39542 10.1002/acr.21688 10.3899/jrheum.130588 10.1136/ard.2009.108217 10.1111/1756-185X.12579 10.1136/annrheumdis-2012-202389 10.1185/03007990802457040 10.1136/ard.2008.097774 10.1136/annrheumdis-2013-203967 10.1093/rheumatology/ker377 10.1007/1-4020-5511-0 10.1093/rheumatology/kep457 10.1002/art.38140 10.1002/acr.23534 10.1186/s13075-018-1724-7 10.1136/ard.2009.124206 10.1097/BOR.0000000000000071 10.1002/art.38973 10.1136/annrheumdis-2013-204231
Clinical Rheumatology; Hunter T, Sandoval D et. al.
Feb 21st, 2021 - The aim of this study was to compare the symptoms, treatment patterns, and quality of life (QoL) of ankylosing spondylitis (AS) patients to non-radiographic axial spondyloarthritis (nr-axSpA) patients in the USA. A cross-sectional survey was condu...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88a548d1-97c0-46d0-825a-75ef689d6470
Feb 21st, 2021 - Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets and naproxen sodium ta...
News 769 results
https://www.staging.medscape.com/viewarticle/940709
Nov 9th, 2020 - Patients with active ankylosing spondylitis (AS) experienced rapid clinical response to the oral Janus kinase (JAK) inhibitor tofacitinib (Xeljanz) in a phase 3, randomized, double-blind, placebo-controlled study. Tofacitinib was significantly mor...
https://www.medscape.com/viewarticle/940709
Nov 9th, 2020 - Patients with active ankylosing spondylitis (AS) experienced rapid clinical response to the oral Janus kinase (JAK) inhibitor tofacitinib (Xeljanz) in a phase 3, randomized, double-blind, placebo-controlled study. Tofacitinib was significantly mor...
https://reference.medscape.com/viewarticle/932588_4
Jul 1st, 2020 - The age of onset of AS is usually from the late teens to 40 years. Onset in persons older than 50 years is unusual, although diagnosis of mild or asymptomatic disease may be made at a later age. Insidious onset of low back pain is the most common ...
https://reference.medscape.com/viewarticle/932588_1
Jul 1st, 2020 - Ankylosing spondylitis (AS) is a chronic, multisystem inflammatory disorder primarily affecting the axial skeleton and sacroiliac joints. AS is one of the seronegative spondyloarthropathies, which are multisystem inflammatory diseases that affect ...
https://reference.medscape.com/viewarticle/932588
Jul 1st, 2020 - Ankylosing spondylitis (AS) is a chronic, multisystem inflammatory disorder primarily affecting the axial skeleton and sacroiliac joints. AS is one of the seronegative spondyloarthropathies, which are multisystem inflammatory diseases that affect ...